MITF and melanoma: We previously observed that Rac1-Src signaling appears to drive BRAFi/MEKi resistance selectively in less differentiated melanoma cell lines such as A375 and 451Lu, which display downregulated MITF target gene expression and upregulated YAP/TAZ target gene expression [15].